Oruka Therapeutics's total assets for Q3 2025 were $509.25M, an increase of 42.48% from the previous quarter. ORKA total liabilities were $22.46M for the fiscal quarter, a 63.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.